Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peijia Jiang

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Cell Death Discovery|June 10, 2026
Mechanistic analysis of MLKL-driven cell survivalPeijia Jiang, Xiaoyang Liu, Mauricio J Reginato, et al.
Cell Death & Disease|February 20, 2025
Inactivation of necroptosis-promoting protein MLKL creates a therapeutic vulnerability in colorectal cancer cellsPeijia Jiang, Sandhya Chipurupalli, Byong Hoon Yoo, et al.
Cell Death & Disease|September 1, 2023
Three-dimensional growth sensitizes breast cancer cells to treatment with ferroptosis-promoting drugsSandhya Chipurupalli, Peijia Jiang, Xiaoyang Liu, et al.
Frontiers in Immunology|February 14, 2022
Killer Cell Immunoglobulin-Like Receptor Haplotype B Modulates Susceptibility to EBV-Associated Classic Hodgkin LymphomaPeijia Jiang, Ilja M Nolte, Bouke G Hepkema, et al.
Cancers|January 27, 2021
Interaction between ERAP Alleles and HLA Class I Types Support a Role of Antigen Presentation in Hodgkin Lymphoma DevelopmentPeijia Jiang, Rianne N Veenstra, Annika Seitz, et al.
Cell Death & Disease|August 6, 2022
ErbB2/Her2-dependent downregulation of a cell death-promoting protein BLNK in breast cancer cells is required for 3D breast tumor growthXiaoyang Liu, Sandhya Chipurupalli, Peijia Jiang, et al.
Cancers|November 27, 2021
HLA Expression in Relation to HLA Type in Classic Hodgkin Lymphoma PatientsGeok Wee Tan, Peijia Jiang, Ilja M Nolte, et al.
Cell Death and Differentiation|January 16, 2019
MORC2 regulates C/EBPα-mediated cell differentiation via sumoylationJia Liu, Qing Zhang, Banlai Ruan, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Cell Death Discovery|June 10, 2026
Mechanistic analysis of MLKL-driven cell survivalPeijia Jiang, Xiaoyang Liu, Mauricio J Reginato, et al.
Cell Death & Disease|February 20, 2025
Inactivation of necroptosis-promoting protein MLKL creates a therapeutic vulnerability in colorectal cancer cellsPeijia Jiang, Sandhya Chipurupalli, Byong Hoon Yoo, et al.
Cell Death & Disease|September 1, 2023
Three-dimensional growth sensitizes breast cancer cells to treatment with ferroptosis-promoting drugsSandhya Chipurupalli, Peijia Jiang, Xiaoyang Liu, et al.
Frontiers in Immunology|February 14, 2022
Killer Cell Immunoglobulin-Like Receptor Haplotype B Modulates Susceptibility to EBV-Associated Classic Hodgkin LymphomaPeijia Jiang, Ilja M Nolte, Bouke G Hepkema, et al.
Cancers|January 27, 2021
Interaction between ERAP Alleles and HLA Class I Types Support a Role of Antigen Presentation in Hodgkin Lymphoma DevelopmentPeijia Jiang, Rianne N Veenstra, Annika Seitz, et al.
Cell Death & Disease|August 6, 2022
ErbB2/Her2-dependent downregulation of a cell death-promoting protein BLNK in breast cancer cells is required for 3D breast tumor growthXiaoyang Liu, Sandhya Chipurupalli, Peijia Jiang, et al.
Cancers|November 27, 2021
HLA Expression in Relation to HLA Type in Classic Hodgkin Lymphoma PatientsGeok Wee Tan, Peijia Jiang, Ilja M Nolte, et al.
Cell Death and Differentiation|January 16, 2019
MORC2 regulates C/EBPα-mediated cell differentiation via sumoylationJia Liu, Qing Zhang, Banlai Ruan, et al.
Pageof 1